These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 14067581)

  • 21. Renal function in gout; with a commentary on the renal regulation of urate excretion, and the role of the kidney in the pathogenesis of gout.
    GUTMAN AB; YU TF
    Am J Med; 1957 Oct; 23(4):600-22. PubMed ID: 13469831
    [No Abstract]   [Full Text] [Related]  

  • 22. Renal excretion of hypoxanthine and xanthine in primary gout.
    Puig JG; Mateos FA; Jiménez ML; Ramos TH
    Am J Med; 1988 Oct; 85(4):533-7. PubMed ID: 3177401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Uric acid clearance in normal and gouty subjects].
    SALA G; BALLABIO CB; AMIRA A
    Reumatismo; 1955; 7(4):223-8. PubMed ID: 13280922
    [No Abstract]   [Full Text] [Related]  

  • 24. [The renal regulation of urate excretion and its relationship to the etiology of gout].
    BISHOP C
    Arch Interam Rheumatol; 1962 Mar; 5():5-15. PubMed ID: 13869489
    [No Abstract]   [Full Text] [Related]  

  • 25. Lead chelation therapy and urate excretion in patients with chronic renal diseases and gout.
    Lin JL; Yu CC; Lin-Tan DT; Ho HH
    Kidney Int; 2001 Jul; 60(1):266-71. PubMed ID: 11422760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal excretion of urate in normal and gouty subjects at high, normal and low plasma urate levels.
    Fontenaille C; Guiheneuc P; Heron B; Prost A; Lucas J
    Biomedicine; 1974 Sep; 21(9):382-5. PubMed ID: 4457158
    [No Abstract]   [Full Text] [Related]  

  • 27. SERUM AND URINARY AMINO ACIDS IN NORMOURICEMIC AND HYPERURICEMIC SUBJECTS.
    KAPLAN D; BERNSTEIN D; WALLACE SL; HALBERSTAM D
    Ann Intern Med; 1965 Apr; 62():658-66. PubMed ID: 14274830
    [No Abstract]   [Full Text] [Related]  

  • 28. Renal impairment and gout.
    Gibson T; Highton J; Potter C; Simmonds HA
    Ann Rheum Dis; 1980 Oct; 39(5):417-23. PubMed ID: 7436572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The treatment of gout and disorders of uric acid metabolism with allopurinol.
    Ogryzlo MA; Urowitz MB; Weber HM; Houpt JB
    Can Med Assoc J; 1966 Nov; 95(22):1120-7. PubMed ID: 5923471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hereditary nephropathy associated with hyperuricemia and gout.
    Puig JG; Miranda ME; Mateos FA; Picazo ML; Jiménez ML; Calvin TS; Gil AA
    Arch Intern Med; 1993 Feb; 153(3):357-65. PubMed ID: 8427538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. URATE DIURETIC THERAPY IN CHRONIC GOUT; A COMPARATIVE STUDY OF PROBENECID AND SULFINPYRAZONE.
    VELAYOS EE; SMYTH CJ
    Arch Intern Med; 1965 Aug; 116():212-9. PubMed ID: 14318478
    [No Abstract]   [Full Text] [Related]  

  • 32. URIC ACID, CALCIUM AND PHOSPHORUS CLEARANCES IN NORMAL SUBJECTS ON A LOW CALCIUM, LOW PHOSPHORUS DIET: URIC ACID, CALCIUM AND PHOSPHORUS CLEARANCES AFTER CLACIUM INFUSION IN NORMAL AND GOUTY PATIENTS.
    DUARTE CG; BLAND JH
    Metabolism; 1965 Mar; 14():203-10. PubMed ID: 14261405
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of renal function on pharmacokinetics and pharmacodynamics of lesinurad in adult volunteers.
    Gillen M; Valdez S; Zhou D; Kerr B; Lee CA; Shen Z
    Drug Des Devel Ther; 2016; 10():3555-3562. PubMed ID: 27843295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Who makes uric acid stones and why--observations from a renal stones clinic.
    Stansbridge EM; Griffin DG; Walker V
    J Clin Pathol; 2013 May; 66(5):426-31. PubMed ID: 23454727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uric acid excretion in gouty and nongouty subjects.
    Colton RS; Maher FT; Ward LE; Ferguson RH
    Mayo Clin Proc; 1966 May; 41(5):326-33. PubMed ID: 5932618
    [No Abstract]   [Full Text] [Related]  

  • 36. The molecular insight into the antihyperuricemic and renoprotective effect of Shuang Qi gout capsule in mice.
    Kodithuwakku ND; Feng YD; Zhang YY; Pan M; Fang WR; Li YM
    J Ethnopharmacol; 2015 Apr; 163():278-89. PubMed ID: 25614106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparative study of uric acid renal elimination in the gout patients and normal patients in spontaneous or experimentally increased or decreased uricemia].
    Prost A; Fontenaille C; Guiheneuc P; Héron B; Lucas J
    Rev Rhum Mal Osteoartic; 1974 Jan; 41(1):33-9. PubMed ID: 4820524
    [No Abstract]   [Full Text] [Related]  

  • 38. Ethanol induced alterations of uric acid metabolism.
    Faller J; Fox IH
    Adv Exp Med Biol; 1984; 165 Pt A():457-62. PubMed ID: 6720411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ABCG2 as a therapeutic target candidate for gout.
    Fujita K; Ichida K
    Expert Opin Ther Targets; 2018 Feb; 22(2):123-129. PubMed ID: 29264928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lesinurad, a novel, oral compound for gout, acts to decrease serum uric acid through inhibition of urate transporters in the kidney.
    Miner JN; Tan PK; Hyndman D; Liu S; Iverson C; Nanavati P; Hagerty DT; Manhard K; Shen Z; Girardet JL; Yeh LT; Terkeltaub R; Quart B
    Arthritis Res Ther; 2016 Oct; 18(1):214. PubMed ID: 27716403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.